Phosphoproteomic Response To MEK Inhibition
Ontology highlight
ABSTRACT: SILAC Heavy and Light cells were treated for 24 hours with each MEKi vs. Control in duplicate (Heavy/Light as well as Light/Heavy). For phosphoproteomic analysis, cells were treated for either 30 minutes or 24 hours with each MEKi vs. Control.
INSTRUMENT(S): LTQ Orbitrap, Exactive Plus
ORGANISM(S): Homo Sapiens (human)
DISEASE(S): Skin Melanoma
SUBMITTER: Christopher Tape
LAB HEAD: Chris Marshall
PROVIDER: PXD002621 | Pride | 2019-11-12
REPOSITORIES: Pride
ACCESS DATA